MEDIA STATEMENT
11th August 2009

JAMA.2009;302(6):649-659
Andrew T Chan, M.D., M.P.H. et al


This study reinforces existing data on the use of aspirin in colorectal cancer.

These long standing professional surveys by the Boston medical team have been providing a range of new insights into the life saving benefits of aspirin today. This extends to strokes, heart attacks and other life-threatening conditions.

In fact a large number of people world-wide considered to be at specific risk of developing these conditions are taking a daily low dose aspirin on medical advice to improve general health and life expectancy.

This new work in colorectal cancer importantly defines the specific mechanisms involved like the part played by Cox-2 over-expression as an important diagnostic factor.

Dr Chan and his colleagues have provided a significant step forward in the continuing world-wide studies on the benefits of aspirin recorded over the hundred years plus of its life.